TradeStation

Get Cash Back and $0 Commissions
+ The Power of TradeStation

Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models

ACCESSWIRE 12-Nov-2024 9:02 AM

Data presented at Society for Immunotherapy of Cancer (SITC) 2024

Systemic DNase I combined with